AMGN - Company ID 0000318154
The table below shows AMGEN INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $8.62B | $9.56B | $9.18B | $8.15B | $8.50B | $8.39B |
| Cost of revenue | $2.74B | $3.08B | $3.01B | $2.97B | $3.31B | $3.24B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
AMGEN INC reported annual revenue of $36.75B for fiscal year 2025. That is up 10.0% from $33.42B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $22.99B (FY 2016) to $36.75B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $1.60B |
| $1.72B |
| $1.69B |
| $1.69B |
| $1.63B |
| $1.78B |
| Operating income | $2.67B | $2.53B | $2.66B | $1.18B | $2.05B | $1.91B |
| Income tax | $265.00M | $705.00M | $136.00M | $243.00M | $271.00M | $48.00M |
| Net income | $1.82B | $3.22B | $1.43B | $1.73B | $2.83B | $746.00M |
| EPS (diluted) | $3.34 | $5.93 | $2.65 | $3.20 | $5.22 | $1.38 |